罗哌卡因复合舒芬太尼用于剖宫产麻醉的临床效果分析

Clinical Effect Analysis of Ropivacaine Combined with Sufentanil for Cesarean Section Anesthesia

目的探讨分析罗哌卡因复合舒芬太尼应用于剖宫产麻醉的临床效果。方法选取我院于2017年3月至2018年3月收治的800例剖宫产产妇作为本次研究对象,采用随机数表的方式分为对照组与观察组,两组各400例。给予对照组产妇应用罗哌卡因进行麻醉,观察组则采用罗哌卡因复合舒芬太尼进行麻醉干预,观察对比麻醉效果。结果两组产妇手术时间以及新生儿Apgar评分对比均无统计学意义(P>0.05),但观察组产妇的镇痛时间、术后疼痛评分以及麻醉起效时间均显著优于对照组,差异具有统计学意义(P<0.05);观察组产妇SBP、DBP、MAP均显著低于对照组,差异具有统计学意义(P<0.05)。结论给予剖宫产产妇应用罗哌卡因复合舒芬太尼进行麻醉,效果显著,减轻产妇疼痛,稳定血压水平,具有临床应用推广价值。

Objective To investigate the clinical effect of ropivacaine combined with sufentanil for cesarean section anesthesia. Methods Eight hundred cesarean section women who were admitted to our hospital from March 2017 to March 2018 were selected as the subjects of the study. They were divided into the control group and the observation group by random number table, and 400 cases in each group. The control group was given ropivacaine for anesthesia, while the observation group was given ropivacaine combined with sufentanil for anesthesia intervention.Observe and compare of anesthetic effect. Results There was no significant difference in maternal operation time and neonatal apgar score between the two groups(P> 0.05). However, the analgesic time, postoperative pain score and anesthesia onset time of the observation group were significantly better than those of the control group. The difference was statistically significant(P< 0.05). The SBP, DBP and MAP of the observation group were significantly lower than those of the control group, the difference was statistically significant(P<0.05). Conclusion Anesthesia with ropivacaine combined with sufentanil for cesarean section is effective, which can reduce maternal pain and stabilize blood pressure.It has clinical application value.